Filing Details

Accession Number:
0001209191-20-038975
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-25 18:00:06
Reporting Period:
2020-06-23
Accepted Time:
2020-06-25 18:00:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808158 Repare Therapeutics Inc. RPTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1477123 Mitchell Lloyd Segal C/O Repare Therapeutics Inc.
7210 Frederick-Banting, Suite 100
St-Laurent A8 H4S 2A1
President And Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-23 5,000 $20.00 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 148,466 Indirect See Footnote
Footnotes
  1. These securities are held by 3996953 Canada Inc. (the "Company"). The Reporting Person is the sole stockholder of the Company.